While both Novel Retatrutide and Intra-articular Durolane target articular soreness, their mechanisms of function are significantly contrasting. Retatrutide is a combined receptor affecting GLP-1 and the GIP receptor, primarily used for body management , which potentially secondarily reduce inflamma